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Summary
Mycobacterium tuberculosis inhibits optimal T helper type 1 (Th1)
responses during infection. However, the precise mechanisms by which
virulent M. tuberculosis limits Th1 responses remain unclear. Here, we
infected dendritic cells (DCs) with the virulent M. tuberculosis strain
H37Rv or the attenuated strain H37Ra to investigate the phenotypic and
functional alterations in DCs and resultant T-cell responses. H37Rv-
infected DCs suppressed Th1 responses more strongly than H37Ra-
infected DCs. Interestingly, H37Rv, but not H37Ra, impaired DC surface
molecule expression (CD80, CD86 and MHC class II) due to prominent
interleukin-10 (IL-10) production while augmenting the expression of
tolerogenic molecules including PD-L1, CD103, Tim-3 and indoleamine
2,3-dioxygenase on DCs in a multiplicity-of-infection (MOI) -dependent
manner. These results indicate that virulent M. tuberculosis drives imma-
ture DCs toward a tolerogenic phenotype. Notably, the tolerogenic pheno-
type of H37Rv-infected DCs was blocked in DCs generated from IL-10/
mice or DCs treated with an IL-10-neutralizing monoclonal antibody,
leading to restoration of Th1 polarization. These findings suggest that
IL-10 induces a tolerogenic DC phenotype. Interestingly, p38 mitogen-
activated protein kinase (MAPK) activation predominantly mediates IL-10
production; hence, H37Rv tends to induce a tolerogenic DC phenotype
through expression of tolerogenic molecules in the p38 MAPK–IL-10 axis.
Therefore, suppressing the tolerogenic cascade in DCs is a novel strategy
for stimulating optimal protective T-cell responses against M. tuberculosis
infection.
Keywords: interleukin-10; p38 mitogen-activated protein kinase; Th1-type
T-cell proliferation; tolerogenic dendritic cells; virulence.
Introduction
Mycobacterium tuberculosis is a successful human bacterial
pathogen that causes tuberculosis (TB), one of the major
causes of human death by infection.1 Despite the great
time and effort spent researching M. tuberculosis,
elucidation of its pathogenesis remains ongoing. A robust
T helper type 1 (Th1) response has widely been consid-
ered essential for providing immunity against TB.2 How-
ever, M. tuberculosis possesses diverse immune evasion
mechanisms that can overcome host defences during
infection. Once targeted cells of the host such as
Abbreviations: BMDCs, bone marrow-derived DCs; DCs, dendritic cells; ELISA, enzyme-linked immunosorbent assay; ERK, ex-
tracellular signal-regulated kinase; HRP, horseradish peroxidase; IDO, indoleamine 2,3-dioxygenase; IFN-c, interferon-c; IL, inter-
leukin; JNK, Jun-N-terminal kinase; mAbs, monoclonal antibodies; MAPK, mitogen-activated protein kinase; MOI, multiplicity
of infection; PE, phycoerythrin; PerCP, Peridinin chlorophyll protein; TB, tuberculosis; TGF-b, transforming growth factor-b;
Th1, T helper type 1; TNF-a, tumour necrosis factor-a; WT, wild-type
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macrophages and dendritic cells (DCs) are infected by
M. tuberculosis, these cells attempt to kill the M. tubercu-
losis via cellular processes such as autophagy and phago-
some–lysosome fusion. However, if the host cells fail to
control M. tuberculosis growth, the bacteria survive and
manipulate host cells for immune evasion.3,4 Although
the cellular mechanisms shared between immune defence
and evasion are relatively well-studied, the phenotypic
and functional alterations of M. tuberculosis-infected
immune cells are not yet clearly understood.
The genetic diversity of M. tuberculosis results in varia-
tion in virulence that induces marked differences in
pathogenesis,5 including bacterial counts, and in immune
responses, such as lung inflammation, chemokine and
cytokine profiles,6 and cell death processes.7 In addition,
the outcome of protective T-cell immunity clearly
depends on the M. tuberculosis strain. Hence, differences
in virulence among M. tuberculosis strains may initially
affect the function and phenotype of antigen-presenting
cells, such as DCs. For example, the virulent strain
H37Rv, but not the attenuated strain H37Ra, induces
necrosis by disrupting the mitochondrial inner mem-
brane,7 and H37Rv up-regulates Th2-type cytokines such
as interleukin-5 (IL-5), IL-10 and IL-13 compared with
H37Ra in macrophages in vitro.6 As another example, the
virulent strain S7 from South India suppresses the Th1
response more than the less virulent strain S10.8 Hence,
investigating different cell death processes, cytokine secre-
tion profiles, and effector expression levels in DCs in the
presence of different bacterial strains of varying virulence
is essential to determine the optimal Th1-type T-cell
response during the early phase of infection and to
understand how virulent M. tuberculosis subverts host
protective immunity.
Dendritic cells are the most important antigen-present-
ing cells for defending M. tuberculosis infection because
they prime and educate T cells in draining lymph nodes.
Consequently, these T cells migrate to infected tissues to
combat M. tuberculosis. Hence, the generation of protec-
tive Th1-type T cells against M. tuberculosis infection
depends on the speed or mechanism by which different
DCs translate and deliver information about the infection
to T cells. In other words, the initial encounter between
DCs and M. tuberculosis is the first critical step that
determines the type and velocity of the T-cell response.
Hence, understanding the nature of DC maturation and
phenotypic changes in response to M. tuberculosis strains
of varying virulence is of great interest for the develop-
ment of an effective TB vaccine and new immunological
interventions to control M. tuberculosis infection.
It is well documented that DCs differentiate into
mature phenotype in response to various inflammatory
stimuli, such as microbial products or cytokines, and then
prime na€ıve T cells to proliferate and engage in an effec-
tive T-cell immune response. In general, mature DCs are
characterized according to phenotypic and functional
changes, such as enhanced expression of MHC class I and
II molecules, co-stimulatory molecules (CD80, CD86, and
CD40) and a variety of innate cytokines. With respect to
M. tuberculosis infection, DCs perform important func-
tions in containing and killing M. tuberculosis by induc-
ing T-cell responses.3,9
After DCs take up M. tuberculosis, they migrate to sec-
ondary lymphoid organs to prime T cells. Activated T
cells proliferate and migrate to the site of infection. Once
a sufficient number of effector T cells accumulates at the
infection site, M. tuberculosis growth becomes hindered.
However, T-cell responses to M. tuberculosis infection are
relatively delayed and impaired compared with T-cell
responses to infection with other intracellular patho-
gens.10 The mechanism underlying the delay in T-cell
responses to M. tuberculosis infection is currently uncer-
tain, but several studies reported that IL-10 is one factor
that is involved in this delay.11,12 The levels of
immunoregulatory cytokines, such as IL-5, IL-10 and IL-
13, are increased in monocytes and monocyte-derived
macrophages in the presence of a virulent strain of M. tu-
berculosis compared with those in an attenuated strain.6,13
Many studies have reported that innate and adaptive cells
are associated with pathogenesis during M. tuberculosis
infection.14 However, the interaction between the DC
phenotype according to M. tuberculosis virulence and the
T-cell response has not been thoroughly studied.
One mechanism by which virulent M. tuberculosis
might subvert T-cell responses could be alteration of DC
function and phenotype. Hence, in this study, we hypoth-
esized that a highly virulent M. tuberculosis strain would
drive immature DCs towards a tolerogenic phenotype,
thereby preventing an optimal Th1 response. To address
this hypothesis, we infected DCs with the two most thor-
oughly studied laboratory-adapted reference strains
M. tuberculosis H37Rv and H37Ra, which are virulent
and attenuated strains, respectively, to gain insight into
DC responses and consequent changes in T-cell polariza-
tion. In addition, we dissected the precise mechanism by
which virulent M. tuberculosis regulates the phenotype
and function of DCs. These findings will help us to
understand how TB manipulates the host immune system
toward pathogen-favouring conditions by interacting with
DCs.
Materials and methods
Experimental animals and ethics statement
Specific pathogen-free female 6- to 8-week-old wild-type
(WT) C57BL/6 (H-2Kb and I-Ab), IL-10/ transgenic
C57BL/6, and OT-II ovalbumin peptide 323–339
(OVA323-339) specific T-cell receptor transgenic C57BL/6
mice were purchased from the Jackson Laboratory (Bar
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Harbor, ME). The experimental protocols used in this
study were reviewed and approved by the Ethics Commit-
tee and Institutional Animal Care and Use Committee
(Permit Number: 2014-0055) of the Laboratory Animal
Research Centre at Yonsei University College of Medicine
(Seoul, Korea).
Antibodies and reagents
Recombinant mouse granulocyte–macrophage colony-sti-
mulating factor (GM-CSF) was purchased from Creagene,
Inc. (Seoul, Korea), and an FITC-Annexin V/propidium
iodide (PI) kit was purchased from BD Biosciences (San
Diego, CA). LIVE/DEAD Fixable Dead Cell Stain Kits
were purchased from Molecular Probes (Carlsbad, CA).
The OT-II peptide (OVA323-339, ISQAVHAAHAEI-
NEAGR) was synthesized by AbFrontier (Seoul, Korea).
The anti-phosphorylated (p-) extracellular signal-regu-
lated kinase (ERK) 1/2, anti-p-Jun N-terminal kinase
(JNK), anti-p-p38, anti-p-Akt (Ser473), and anti-p-GSK-
3b (Ser9) monoclonal antibodies (mAbs) were obtained
from Cell Signaling Technology, Inc. (Beverly, MA).
Inhibitors of ERK (U0126), JNK (JNK inhibitor II), and
p38 (SB203580) were purchased from Calbiochem (San
Diego, CA), and Wortmannin was purchased from
Sigma-Aldrich Chemical Co. (St Louis, MO). Horseradish
peroxidase (HRP) -conjugated anti-mouse IgG and HRP-
conjugated anti-rabbit IgG were obtained from Cal-
biochem. Phycoerythrin (PE) -conjugated mAbs against
CD80, MHC-II, PD-L1 (CD274), FoxP3 and GATA-3;
PE-Cy7-conjugated mAbs against CD11c and T-bet and
CD25; the Peridinin chlorophyll protein (PerCP) -Cy5.5
or FITC-conjugated mAbs against CD4; PerCP-Cy5.5-
conjugated indoleamine 2,3-dioxygenase (IDO); allophy-
cocyanin-conjugated mAbs against CD49b, CD86, CD103
and RORct; and PerCP-eFluor710-conjugated mAbs
against CD223 (LAG-3) were purchased from eBioscience
(San Diego, CA). Tumour necrosis factor-a (TNF-a),
IL-5, IL-10, IL-12p70, IL-17A, transforming growth fac-
tor-b (TGF-b) and interferon-c (IFN-c) ELISA kits were
obtained from eBioscience. Anti-mouse CD3e (145-2C11
and anti-mouse CD28 (37.51) were also purchased from
eBioscience. The neutralizing anti-PD-L1 and anti-IL-10
mAbs (10F.9G2 and JESS-2A5, respectively) and their
respective isotype controls rat IgG2b (LTF-2) and rat
IgG1 (HRPN) were purchased from BioXCell (West
Lebanon, NH).
Mycobacterium tuberculosis strains and culture
conditions
The M. tuberculosis H37Rv (ATCC 27294) and H37Ra
(ATCC 25177) strains were obtained from the American
Type Culture Collection (ATCC, Manassas, VA). The cul-
tures and single-cell suspensions of each strain were
prepared as previously described.15 The seed lots of each
strain were kept in small aliquots at 80° until use. After
confirmation of the predominant presence of single cells
in the final preparation based on acid-fast staining, the
number of colony-forming units (CFUs) per 1 ml of each
seed lot on a 7H10 agar plate was measured using a
viable cell counting assay, and the cells were used for the
subsequent experiments.
Generation and culture of bone marrow-derived DCs
(BMDCs)
Generation and culture of DCs from murine bone marrow
cells were performed in the presence of GM-CSF as previ-
ously described.16 Briefly, whole bone marrow cells isolated
from C57BL/6 mice were lysed with red blood cell lysing
buffer and washed with RPMI-1640 medium. Then, the
cells were plated in six-well culture plates (106 cells/ml)
and incubated at 37° in a 5% CO2 atmosphere in RPMI-
1640 medium supplemented with 100 U/ml penicillin/
streptomycin (Lonza, Basel, Switzerland), 10% fetal bovine
serum (Lonza), 50 lM mercaptoethanol (Lonza), 01 mM
non-essential amino acids (Lonza), and 20 ng/ml GM-CSF.
On day 8, the purity of CD11c-positive non-adherent cells
was confirmed to be > 90%, and this cell population was
used for subsequent experiments.
Comparison of cytotoxicity between M. tuberculosis
strains and determination of MOIs not causing
cytotoxicity to DCs
At 8 days in culture, DCs (2 9 106 cells) were infected
with H37Ra or H37Rv at a MOI of 05, 1 or 5. After
4 hr, amikacin (Sigma-Aldrich) was applied at 20 µg/ml
to kill any extracellular bacteria. After an additional
18 hr, the DCs were harvested, washed with PBS, and
stained using an Annexin V-PI Apoptosis Detection Kit
(BD Biosciences) according to the manufacturer’s proto-
col. Furthermore, the levels of lactate dehydrogenase
(LDH) in the supernatants of M. tuberculosis-infected
DCs were assessed to evaluate DC cytotoxicity. To mea-
sure the viability of the DCs at prolonged time-points
(48, 72 and 96 hr post-M. tuberculosis infection), the
M. tuberculosis-infected DCs were stained using LIVE/
DEAD Fixable Dead Cell Stain Kits according to the
manufacturer’s protocol and analysed using flow
cytometry.
Comparison of M. tuberculosis uptake by DCs
To determine whether DCs uptake a similar number of
the different M. tuberculosis strains, both M. tuberculosis
strains were labelled with the fluorescent Violet Prolifera-
tion Dye 450 (VPD450; BD Biosciences) according to the
manufacturer’s instructions. Briefly, the M. tuberculosis
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strains (2 9 108 CFU/ml) were washed with PBS, diluted
in 1 ml of PBS supplemented with 10 lM of VPD450 and
incubated in a 37° water bath for 15–20 min. Finally, the
VPD450-labelled M. tuberculosis strains were washed
twice in PBS, and the DCs were infected at an MOI of 1
bacterium per cell and analysed at various time-points.
After each time-point, the DCs were harvested, the non-
internalized bacteria were washed off with PBS, and 02%
trypan blue was added to the cells. M. tuberculosis inside
DCs were measured using flow cytometry.
Evaluation of cell surface molecule expression on DCs
using flow cytometry
On day 8 in culture, the BMDCs were harvested and
washed once. Then, 2 9 106 DCs/ml were infected with
M. tuberculosis for 4 hr. Afterwards, Amikacin was
applied at 20 µg/ml. After an additional 18 hr, the har-
vested cells were blocked with 10% (volume/volume) nor-
mal goat serum for 15 min at 4°, followed by staining
with PE-conjugated antibodies against I-Ab (MHC-II),
CD80, or PD-L1, allophycocyanin-conjugated antibodies
against CD86, CD103 or Tim-3, and a PE-Cy7-conjugated
antibody against CD11c for 30 min at 4°. Finally, the
stained cells were analysed using a BD FACSverse flow
cytometer (Becton Dickinson, San Jose, CA) and FLOWJO
software (Tree Star, Inc., Ashland, OR).
ELISA
Supernatants were collected 24 hr after infection and were
stored at 70° until assessment of cytokine production.
The levels of TNF-a, TGF-b, IL-5, IL-10, IL-12p70, IL-
17A and IFN-c were measured using sandwich ELISA kits
(eBioscience) and commercially available pairs of anti-
bodies and standards according to the manufacturer’s
protocol.
Immunoblotting analyses and treatment of DCs with
pharmacological inhibitors of GSK-3b and mitogen-
activated protein kinase pathway members
After infection with M. tuberculosis, DCs were lysed in
200 ll of lysis buffer containing 50 mM Tris–HCl (pH
75), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA,
50 mM NaF, 30 mM Na4PO7, 1 mM PMSF, 2 lg/ml apro-
tinin, and 1 mM pervanadate. Whole-cell lysate samples
were resolved on SDS–polyacrylamide gels and then
transferred to polyvinylidene fluoride membrane for 2 hr
at 80 V. The membranes were blocked in 5% skim milk
and incubated with an antibody overnight, followed by
incubation with a corresponding HRP-conjugated sec-
ondary antibody for 1 hr at room temperature. For detec-
tion of target protein epitopes, polyclonal antibodies
against p-ERK 1/2, p-JNK 1/2, p-p38, p-Akt (Ser473),
and p-GSK-3b (Ser9) (dilutions of 1 : 2000, 1 : 2000,
1 : 2000, 1 : 2000, and 1 : 500, respectively) were used.
Specific protein bands recognized by the antibodies were
visualized using the ECL Advance Western Blotting
Detection kit (GE Healthcare, Little Chalfont, UK). Two
hours before M. tuberculosis infection, inhibitors of ERK
(U0126), JNK (JNK 2 inhibitor), p38 (SB203580), or
GSK-3b (Wortmannin) were applied. After 4 hr of M. tu-
berculosis infection, DCs were treated with 20 µg/ml ami-
kacin, and after an additional 18 hr, the supernatants
were harvested and analysed using ELISA kits.
T-cell proliferation assay
OVA323-339-specific CD4
+ T cells were obtained from the
splenocytes of OT-II mice a MACS column (Miltenyi
Biotec, Bergisch Gladbach, Germany). These T cells were
stained with 125 lM carboxyfluorescein diacetate succin-
imidyl ester (CFSE; Invitrogen). One hour before co-cul-
ture with T cells, DCs (2 9 106 cells/well) were treated
with OVA323-339. Then, the DCs were co-cultured with
CFSE-stained CD4+ T cells (25 9 105 cells/well) at a
DC : T-cell ratio of 1 : 5. At 3 days in co-culture, the T
cells were stained with PerCP-Cy5.5-conjugated anti-CD4,
PE-Cy7-conjugated anti-T-bet, PE-conjugated anti-
GATA-3 and anti-RORct mAbs and analysed through
flow cytometry. Supernatants were also harvested, and the
IFN-c, IL-5 and IL-17A levels were measured via ELISA.
T-cell suppression by M. tuberculosis-infected tolerogenic
DCs
To investigate whether M. tuberculosis H37Rv-infected
tolerogenic DCs are actively involved in T-cell suppres-
sion, we conducted a T-cell suppression assay using previ-
ously described protocols with slight modifications.17–19
Briefly, BMDCs were harvested and infected with M. tu-
berculosis as described above. After 24 hr, the BMDCs
(3 9 104 cells/well) were washed and co-cultured for
72 hr with CD4+ T cells (15 9 105 cells/well) isolated
from the spleen using a MACS system. CD4+ T cells were
labelled with 125 lM CFSE and stimulated with immobi-
lized anti-CD3/28. T-cell proliferation was analysed via
flow cytometry.
Statistical analyses
Statistical analyses were conducted using GRAPHPAD PRISM
V50 (GraphPad Software, San Diego, CA). Differences
between two groups were analysed using an unpaired Stu-
dent’s t-test. One-way analyses of variance followed by
Tukey’s multiple comparison tests were used to analyse
data with more than two groups. All values are expressed
as the means ( SD). Statistical significance was deter-
mined as *P < 005, **P < 001 or ***P < 0001.
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Results
Virulent M. tuberculosis strain-infected DCs impede
T-cell proliferation
As previously reported, an impaired and delayed T-cell
response is a unique hallmark of M. tuberculosis infec-
tion,20 and DCs infected with M. tuberculosis impede
T-cell proliferation.21 To determine the effect of M. tu-
berculosis infection in DCs on the T-cell response, we
first optimized the MOI of M. tuberculosis that would
not cause DC death and could therefore be used in sub-
sequent experiments for flow cytometry analysis (see
Supplementary material, Fig. S1a, b) and measurements
of LDH release (see Supplementary material, Fig. S1c).
Next, we confirmed that DCs were infected with both
M. tuberculosis strains to a similar extent at an MOI of 1
bacterium per cell (see Supplementary material,
Fig. S1d). Furthermore, at an MOI of 1 bacterium per
cell, no differences in cell viability of the DCs infected
with either M. tuberculosis strain were observed until
96 hr after infection (see Supplementary material,
Fig. S1e). We next hypothesized that the differences in
the virulence of different M. tuberculosis strains result
from variations in the ability of DCs infected with differ-
ent strains of M. tuberculosis to activate T cells. To verify
the effect of M. tuberculosis strains of differing virulence
on the T-cell expansion ability of infected DCs, we per-
formed a syngeneic mixed lymphocyte reaction assay
using CD4+ T cells from OT-II transgenic mice. OVA323-339-
specific transgenic CD4+ T cells were labelled with CFSE
and co-cultured with M. tuberculosis-infected DCs at a
5 : 1 ratio for 3 days (Fig. 1). Interestingly, virulent
M. tuberculosis strain H37Rv-infected DCs showed a
weaker ability to induce naive CD4+ T-cell proliferation
than attenuated H37Ra-infected DCs or non-infected
OVA323-339-pulsed DCs (Fig. 1a,b). Next, to verify the
types of T-cell responses induced by M. tuberculosis-
infected DCs, the expression of transcription factors and
cytokines related to Th1 (T-bet and IFN-c) and Th2
responses (GATA-3 and IL-5) and Th17 (RORct and IL-
17A) in co-cultured CD4+ T cells was analysed via flow
cytometry (Fig. 1c,d) and ELISA (Fig. 1e). Compared
with H37Rv-infected DCs, H37Ra-infected DCs induced
stronger T-bet and IFN-c expression in co-cultured T
cells. RORct expression in T cells as well as IL-17A
secretion were higher in T cells subjected to M. tubercu-
losis-infected DCs, but there was no difference between
the two strains. T cells co-cultured with non-infected
OVA323-339-pulsed DCs showed the highest expression
levels of GATA-3, but the overall expression levels of
GATA-3 and IL-5 were not intense in every sample
(Fig. 1d,e). No detectable expression of CD25+ FoxP3+
Treg and CD4+ LAG-3+ CD49b+ CD25 Foxp3 type 1
regulatory T cell (Tr1 cells) as well as no secretion of
IL-10 and TGF-b from T cells co-cultured with M. tu-
berculosis-infected DCs were observed (data not shown).
These results suggest that virulent M. tuberculosis-
infected DCs were not able to induce an effective CD4+
T-cell response.
Infection with M. tuberculosis promotes a tolerogenic
DC phenotype in a virulence-dependent manner
To investigate the reason that virulent M. tuberculosis
H37Rv-infected DCs ineffectively induced T-cell
responses, we measured the expression levels of surface
molecules related to T-cell activation on DCs (Fig. 2).
The gating strategy for each surface molecule and
enzyme is shown in Fig. 2(a). H37Ra-infected DCs dis-
played increasing expression of CD80 and CD86 as the
MOI increased, but H37Rv-infected DCs presented
reduced expression of CD80 and CD86 as the MOI
increased. H37Rv but not H37Ra repressed the expres-
sion of MHC-II as the MOI increased. Moreover, both
M. tuberculosis strains up-regulated CCR7 compared
with its expression in non-infected DCs, and H37Rv-
infected DCs exhibited up-regulation of CCR7 in an
MOI-dependent manner (Fig. 2b). Next, the expression
of inhibitory molecules such as PD-L1, Tim-3, CD103
and IDO was analysed via flow cytometry (Fig. 2c).
H37Rv-infected DCs displayed higher expression of PD-
L1, Tim-3, CD103 and IDO than H37Ra-infected DCs,
and infection at higher MOIs further induced these
molecules. These results suggest that the virulent M. tu-
berculosis strain H37Rv induces a more tolerogenic DC
phenotype than the attenuated M. tuberculosis strain
H37Ra.
The virulent M. tuberculosis strain induces marked
IL-10 production in DCs
Cytokine signalling is a crucial regulator of DC–T-cell
interactions. To verify the cytokine profiles of DCs
infected with different M. tuberculosis strains, the TNF-a,
IL-10 and IL-12p70 levels in cell culture supernatants
were measured (Fig. 3). After 24 hr of M. tuberculosis
infection at an MOI of 05 or 1, H37Rv-infected DCs
secreted two-fold greater levels of TNF-a than H37Ra-
infected DCs (Fig. 3a). Remarkably, H37Rv-infected DCs
induced three-fold greater secretion of IL-10 than
H37Ra-infected DCs; however, IL-12p70 was not detected
in cells infected with either M. tuberculosis strain. To
evaluate the kinetics of each cytokine, DCs were infected
with either M. tuberculosis strains at an MOI of 1, and
the TNF-a, IL-10 and IL-12p70 levels were then mea-
sured via ELISA at 2, 4, 8, 12 and 24 hr after infection
(Fig. 3b). TNF-a was secreted at high levels at the early
time-points, and the secreted level of TNF-a peaked at
8 hr after infection in DCs infected with both
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M. tuberculosis strains. Interleukin-10 secretion increased
rapidly beginning from 4 hr after infection; in particular,
H37Rv-infected DCs showed high secreted IL-10 levels,
which peaked at 12 hr after infection. IL-12p70 was not
detected at any time-point (Fig. 3a,b). Interestingly, the
phenotype of DCs infected with H37Rv showed a similar
phenotype (Fig. 2) and cytokine profile (Fig. 3) to those
of tolerogenic DCs.
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Figure 1. Virulent Mycobacterium tuberculosis-infected dendritic cells (DCs) impede effective T-cell proliferation. At 24 hr after infection with
M. tuberculosis at a multiplicity of infection (MOI) of 1, DCs were pulsed with 05 lg/ml chicken ovalbumin peptide (OVA323-339) for 1 hr.
OVA323-339-specific CD4
+ T cells from OT-II transgenic mice were isolated using a MACS system and were stained with 125 lM CFSE;
OVA323-339 pulse-treated DCs were co-cultured with isolated T cells for 72 hr. (a, b) Proliferation of T cells was analysed via flow cytometry. The
proliferation rate is shown in the histogram and as the proliferation index. (c, d) After 72 hr of co-culture with DCs, T cells were harvested and
stained with anti-CD4, anti-T-bet, anti-GATA-3 and anti-RORct antibodies to analyse the T-cell polarization via flow cytometry. T-bet-, GATA-
3- and RORct-expressing CD4+ T cells are shown in the histogram (c) and bar graphs (d). (e) The interferon-c (IFN-c), interleukni-5 (IL-5) and
IL-17A secretion levels were determined by ELISA. Transforming growth factor-b (TGF-b), IL-10, regulatory T (Treg) cells (CD25+ FoxP3+) and
Tr1 cells (CD4+ LAG-3+ CD49b+ CD25– Foxp3–) were not detected (data not shown). All data are expressed as the mean  SD (n = 3 samples)
of one representative experiment of three independent experiments. n.s, not significant, *P < 005, **P < 001 and ***P < 0001, one-way analy-
sis of variance. no OVA+NI-DCs: non-pulsed non-infected DCs, OVA+NI-DCs: OVA-pulsed non-infected DCs, OVA+Ra-DCs: OVA-pulsed
H37Ra-infected DCs, OVA+Rv-DCs: OVA-pulsed H37Rv-infected DCs. [Colour figure can be viewed at wileyonlinelibrary.com]
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The virulent M. tuberculosis strain-mediated
conditioning of DCs into a tolerogenic phenotype is
mediated by the IL-10 cascade
Virulent H37Rv-infected DCs displayed a tolerogenic phe-
notype that impeded T-cell proliferation and polarization.
Among the factors induced by M. tuberculosis infection in
DCs, IL-10 showed dramatically increased secretion from
H37Rv-infected DCs compared with H37Ra-infected DCs
beginning from early time-points after infection (Fig. 3).
Moreover, previous studies have reported that IL-10
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induces immune tolerance via DCs or tolerogenic DCs
in vitro.22,23 Hence, we focused on IL-10 as a modulator of
the tolerogenic DC phenotype. To verify the effect of IL-10
on the phenotype of M. tuberculosis-infected DCs, H37Rv
and H37Ra were infected into DCs at an MOI of 1, fol-
lowed by treatment of the cells with an anti-IL-10 mAb. At
24 hr after infection, the levels of cytokines (IL-10 and
TNF-a) and DC surface markers (MHC-II, CD80, CD86,
CD103, Tim-3, and PD-L1) were analysed (Fig. 4). The
anti-IL-10 neutralizing antibody functioned properly
(Fig. 4a). The M. tuberculosis infection-induced impair-
ment in the expression of maturation markers, such as
MHC-II, CD80 and CD86 in DCs was ameliorated by
treatment with the anti-IL-10 neutralizing antibody
(Fig. 4b), whereas the expression of tolerogenic molecules,
such as Tim-3, CD103 and PD-L1 were decreased by by the
anti-IL-10 neutralizing antibody in DC treatment (Fig. 4c).
To confirm these results, we generated DCs from bone
marrow cells of IL-10/ mice and obtained similar results.
WT-DCs and DCs derived from IL-10/ mice (IL-10/-
DCs) were infected with H37Rv or H37Ra at an MOI of 1
for 24 hr. Afterwards, the expression of surface molecules
such as CD80, CD86, MHC-II, CD103, Tim-3 and PD-L1
was analysed using flow cytometry, and the production of
cytokines such as IL-10, IL-12p70 and TNF-a was analysed
by ELISA (Fig. 5). The M. tuberculosis infection-induced
impairment in the expression of maturation markers such
as MHC-II, CD80 and CD86 in WT-DCs was ameliorated
in IL-10/-DCs (Fig. 5a), whereas the expression of
tolerogenic molecules such as CD103, Tim-3 and PD-L1
was increased in M. tuberculosis-infected WT-DCs but
decreased in IL-10/-DCs (Fig. 5b). Secretion level of
TNF-a was higher in IL-10/-DCs by infection with either
M. tuberculosis strain. Although WT-DCs did not produce
IL-12p70, IL-10/-DCs secreted IL-12p70. Furthermore,
H37Rv-infected IL-10/-DCs produced fourfold higher
IL-12p70 levels than H37Ra-infected IL-10/-DCs
(Fig. 5c). The restoration of the expression levels of these
molecules in DCs by blocking IL-10 signalling was more
significant following virulent H37Rv infection than follow-
ing attenuated H37Ra infection.
IL-10 secretion from DCs infected with the virulent
M. tuberculosis strain is mediated by the predominant
activation of the p38 mitogen-activated protein kinase
and is partially regulated by the ERK 1/2 signalling
pathway
It has been well documented that IL-10 production in
response to mycobacterial infection is mainly mediated by
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two signalling pathways, the ERK1/2 mitogen-activated
protein kinase (MAPK) and GSK-3b, in macrophages.24,25
To determine the role of different signalling pathways in
M. tuberculosis-induced IL-10 secretion of BMDCs, we
examined the activation of various MAPKs and GSK-3b,
all of which are involved in the production from IL-10 in
response to M. tuberculosis infection (Fig. 6). We
observed the most significant phosphorylation of p38
MAPK in H37Rv-infected DCs. In contrast, there were
relatively lower levels of ERK1/2 MAPK phosphorylation
compared to that of p38 MAPK, and no phosphorylation
of JNK in DCs infected with either strain. We also
observed that GSK-3b (Ser9) and its upstream, Akt,
showed more significant phosphorylation following
H37Rv infection than following H37Ra infection
(Fig. 6a). As the previous study reported that the phos-
phorylation of GSK-3b could be regulated by p38
MAPK,26 we next examined the influence of p38 and
ERK1/2 MAPK signalling on GSK-3b inhibitors in M. tu-
berculosis-infected DCs using specific inhibitors. However,
the inhibition of p38 and ERK signalling had little influ-
ence on GSK-3b phosphorylation (Fig. 6b). We next
examined the involvement of the GSK-3b, p38, ERK and
JNK MAPK signalling pathways in IL-10 production
using inhibitors targeting members of each signalling
pathway. Inhibition of p38 signalling exhibited the most
significant decrease of IL-10 secretion, and ERK signalling
inhibition had a partial effect; however, inhibiting GSK-
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10) or an isotype control antibody (IgG isotype) was applied for 2 hr. Afterwards, the DCs were infected with M. tuberculosis (H37Ra or H37Rv
strain) at a multiplicity of infection (MOI) of 1. (a) To verify the effects of the anti-IL-10 neutralizing mAb and the isotype control mAb, the levels of
IL-10 and tumour necrosis factor-a (TNF-a)in the supernatants were assessed via ELISA. (b and c) The levels of DC surface stimulatory molecules
(MHC class II, CD80, CD86) and tolerogenic molecules (CD103, Tim-3, PD-L1) were analysed via flow cytometry. All data are expressed as the
mean  SD (n = 3 samples) of one representative experiment of three independent experiments. n.s., not significant; *P < 005, **P < 001, and
***P < 0001, between IgG-treated DCs and anti-IL-10 mAb-treated DCs. NI: non-infected DCs, Ra: H37Ra-infected DCs, Rv: H37Rv-infected DCs.
ª 2017 John Wiley & Sons Ltd, Immunology, 151, 177–190 185
Virulent Mtb-induced IL-10 drives tolerogenic DCs
3b signalling had a minimal effect on IL-10 secretion
from M. tuberculosis-infected DCs (Fig. 6c). Taken
together, our data suggest that IL-10, a cytokine that
induces a tolerogenic DC phenotype in response to
M. tuberculosis infection, is primarily regulated via the
p38 MAPK signalling pathway and is partially regulated
via the ERK and GSK-3b pathways.
Infection of IL-10/-DCs with the virulent
M. tuberculosis strain restores the proliferation ability
of T cells
Virulent H37Rv-infected DCs showed limited CD4+ T-cell
proliferation, which resulted from a tolerogenic DC phe-
notype induced by IL-10. Therefore, we analysed the
effect of IL-10 on the proliferation ability of T cells in the
presence of M. tuberculosis-infected DCs. WT-DCs and
IL-10/-DCs were infected or not with virulent H37Rv
at an MOI of 1 and then co-cultured with CD4+ T cells
from OT-II mice. There was no difference in T-cell
proliferation between the two control groups, OVA323-339-
treated WT-DCs and OVA323-339-treated IL-10
/ DCs,
and T-cell proliferation was markedly recovered in
H37Rv-infected IL-10/-DCs compared with that in
H37Rv-infected WT-DCs (Fig. 7a,b). Next, the expression
of the master transcription factors of Th1 cells (T-bet)
and Th2 cells (GATA-3) was evaluated via flow cytometry
(Fig. 7c). The expression of T-bet increased in T cells co-
cultured with H37Rv-infected IL-10/-DCs, but there
was no change in GATA-3 expression following H37Rv
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Figure 5. Absence of interleukin-10 (IL-10) from dendritic cells (DCs) restores the phenotypic and functional activation of DCs despite infection
with virulent Mycobacterium tuberculosis. DCs were derived from wild-type (WT) or IL-10/ mice. Then, the DCs were infected with M. tuber-
culosis (H37Ra or H37Rv strain) at a multiplicity of infection (MOI) of 1. At 24 hr after infection, the levels of the DC surface molecules CD80,
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infection in these cells. IFN-c expression was also recov-
ered in H37Rv-infected IL-10/-DCs (Fig. 7d). More-
over, PD-L1 was highly expressed in DCs infected with
H37Rv (Fig. 2c). Hence, we also co-cultured anti-PD-L1
blocking antibody-treated DCs with CD4+ T cells from
OT-II mice. However, we found no difference in T-cell
proliferation ability between co-culture with anti-PD-L1
blocking antibody-treated DCs and with non-treated DCs
(see Supplementary material, Fig. S2). These results sug-
gest that IL-10 is one factor that impedes effective T-cell
responses by H37Rv-infected DCs.
Discussion
Although numerous studies have examined the functions
and alterations of macrophages during M. tuberculosis
infection, few studies have reported the characteristics of
DCs according to the virulence of M. tuberculosis. In this
study, we investigated how virulent M. tuberculosis
impairs and delays T-cell responses induced by interac-
tions with DCs. A virulent M. tuberculosis strain drove
DCs towards a tolerogenic phenotype by impairing DC-
activating surface markers (CD80, CD86 and MHC class
II) and by augmenting tolerogenic markers, such as PD-
L1, CD103, Tim-3 and IDO, on DCs in an MOI-depen-
dent manner, thereby suppressing Th1 responses. Of note,
M. tuberculosis H37Rv-infected DCs showed markedly
increased IL-10 production beginning from early time-
points of infection through activation of p38 MAPK sig-
nalling pathways. The generation of these tolerogenic DCs
by the virulent M. tuberculosis strain was dependent on
the production of IL-10 by DCs, as neither DCs generated
from IL-10/ mice nor DCs treated with an anti-IL-10
neutralizing antibody generated tolerogenic DCs; conse-
quently, the Th1-type T-cell response was restored in
those DCs.
The immunological environment in lung lesions at the
early stage of infection can be regulated by virulent
M. tuberculosis strains via the manipulation of innate
immune cells and of the cytokine balance. Hence, impair-
ment and delay of T-cell responses are generally believed
to be a unique hallmark of early-stage infection with viru-
lent M. tuberculosis.20 To eliminate intracellular pathogens
such as M. tuberculosis, it is essential to initiate an opti-
mal T-cell response, especially an antigen-specific Th1
response characterized by IFN-c activity. Our previous
study showed that the frequency of CD11bhigh DCs was
significantly increased by infection with either M. tubercu-
losis H37Rv or H37Ra at early time-points,15 although the
frequency of this DC population in response to infection
was not significantly different between the two strains at
14 days post-infection. However, an ex vivo experiment
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showed that infiltrated CD11bhigh DCs after virulent
M. tuberculosis infection suppressed the Th1 response
compared with naive CD11bhigh DCs. These previous
results agree with our current results (Fig. 1), indicating
that virulent M. tuberculosis can suppress the protective
Th1 response by driving DCs towards a tolerogenic
phenotype.
Many studies reported that M. tuberculosis or its prod-
ucts impair DC maturation. For example, M. tuberculosis
infection inhibit the maturation of human monocyte-
derived DCs; M. tuberculosis-infected DCs exhibit an
impaired ability to induce T cell proliferation;21 M. tuber-
culosis antigen heat-shock protein 70 impairs the matura-
tion of murine BMDCs;27 and ManLAM, a glycolipid of
M. tuberculosis, inhibits lipopolysaccharide-induced DC
activation.28 As another example, M. tuberculosis regulates
granuloma formation, dissemination, bacterial growth
and the host immune response by producing virulence
factors such as ESX-1 secretion associated proteins. Carls-
son et al. 29 demonstrated that the ESX-1 secretion sys-
tem is required for granuloma persistence and survival in
immune cells. Importantly, this system is present in viru-
lent strains (M. tuberculosis H37Rv) but is largely absent
from attenuated mycobacterial strains (H37Ra).30,31 These
results agree with our data to a certain extent, in terms of
inhibition of T-cell proliferation by M. tuberculosis
H37Rv-infected DCs. Furthermore, our data demon-
strated that H37Rv infection of DCs led to the develop-
ment of tolerogenic DCs because there was no observed
secondary effect of IL-10 and TGF-b produced from T
cells co-cultured with M. tuberculosis-infected DCs on the
inhibition of T-cell proliferation (data not shown). In
addition, DCs infected with the virulent M. tuberculosis
strain were actively involved in the suppression of T-cell
proliferation in the presence of polyclonal stimulation
with anti-CD3e and anti-CD28 in a population-depen-
dent manner (see Supplementary material, Fig. S3)
Regarding the role of IL-10 in M. tuberculosis infection,
several studies have been reported with controversial
results. Some groups reported no difference in bacterial
load or resistance to M. tuberculosis between IL-10/
and WT C57BL/6 mice,32–34 even though IL-10/ mice
showed enhanced IFN-c expression.34 In contrast, a
decreased bacterial load together with an enhanced IFN-c
response in the lungs was detected in IL-10/ mice com-
pared with WT mice.11,35 In another previous study, pre-
treatment of mice with an anti-IL-10 antibody resulted in
an increase in the abundance of Ag85B-specific P25 T-cell
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receptor-transgenic CD4+ Th1 cells in the M. tuberculosis-
infected lung on day 21 post-infection, whereas neutral-
ization of TGF-b, another important suppressive cytokine
in the lung, showed no effects on Th1 induction.4 As
revealed in this study, marked IL-10 production in DCs
in response to virulent M. tuberculosis H37Rv infection is
the most important factor that alters the phenotype of
DCs towards a tolerogenic state and, consequently, sup-
presses the Th1 response (Figs 4, 5 and 7). In addition,
pulmonary DCs were reported to suppress the Th1
response via IL-10 production.36 Hence, a virulent M. tu-
berculosis strain may exploit innately programmed sup-
pressive mechanisms in the lungs to suppress the Th1
response at the early stage of infection.
Diverse signalling pathways have been known to regu-
late the production of IL-10. It was reported that ERK
MAPK signalling is one major signalling pathway induc-
ing IL-10 production in M. tuberculosis-infected macro-
phages.37,38 However, this study indicated that blocking
the p38 pathway had a greater effect on IL-10 production
than blocking the ERK signalling pathway (Fig. 6c). This
difference may have resulted from differences between cell
types. According to previous studies, macrophages and
DCs showed different degrees of ERK phosphorylation
and IL-10 production in response to stimulation by Toll-
like receptors 9 and 4.39 In addition, IL-10 was produced
by neutrophils40 and human lung epithelial cells41
through p38 MAPK signalling pathway activity in
response to bacillus Calmette–Guerin. These results indi-
cated that the signalling pathways involved in IL-10 pro-
duction may differ among innate immune cells in
response to specific stimuli.
The importance of IL-10 in DCs for the induction of
immune tolerance has largely been demonstrated. For
example, DCs genetically modified to express IL-10 exert
suppressive effects in models of alloreactivity and autoim-
munity.42,43 In this regard, Jarnicki et al.44 demonstrated
that inhibition of p38 MAPK-dependent IL-10 secretion
from DCs led to stronger Th1 responses and weaker regu-
latory T-cell responses. These findings indicate that the
tolerogenic DC phenotype generated in response to
H37Rv can be overcome by inhibiting p38 signalling in
DCs. Additionally, p38 may serve as an important thera-
peutic target, and p38 signalling is a potential mechanism
for enhancing the efficacy of the Th1 response via vaccine
or immunological interventions.
Current TB pathogenesis paradigms are changing in con-
sideration of pathogen diversity because greater virulence
has been identified in M. tuberculosis clinical isolates than
was previously anticipated.45 Hence, a further understand-
ing of the characteristics of immune cells depending on
M. tuberculosis virulence may facilitate the rational design
of more effective therapeutic interventions, including
immunotherapeutic vaccines. In conclusion, the findings of
our study suggest that the virulent M. tuberculosis strain
H37Rv impeded effective T-cell responses by inducing
marked IL-10 release from infected DCs via the dominant
activation of the p38 MAPK signalling pathway and partial
regulation of the ERK MAPK signalling pathway. Hence,
virulentM. tuberculosis may drive the production of patho-
gen-favourable tolerogenic DCs to diminish protective Th1
responses and may contribute to the inability of the host to
eradicate the infection. Further functional analysis of the
direct interplay between the components of M. tuberculosis
that induce IL-10 production and alter DC maturation and
the functionality of T cells may help us to understand how
virulent M. tuberculosis evolved immunologically as the
most highly adapted human pathogen.
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